Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

• Main Authors: Jing-Tao Gao (Author), Juan Du (Author), Gui-Hui Wu (Author), Yi Pei (Author), Meng-Qiu Gao (Author), Leonardo Martinez (Author), Lin Fan (Author), Wei Chen (Author), Li Xie (Author), Yu Chen (Author), Hua Wang (Author), Long Jin (Author), Guo-Bao Li (Author), Pei-Lan Zong (Author), Yu Xiong (Author), Qian-Hong Wu (Author), Ming-Wu Li (Author), Xiao-Feng Yan (Author), Yan-Fang Miao (Author), Qing-Shan Cai (Author), Xin-Jie Li (Author), Da-Peng Bai (Author), Shu-Jun Geng (Author), Guo-Li Yang (Author), Pei-Jun Tang (Author), Yi Zeng (Author), Xiao-Hong Chen (Author), Tong-Xia Li (Author), Cui Cai (Author), Yun Zhou (Author), Ma Zhuo (Author), Jian-Yun Wang (Author), Wen-Long Guan (Author), Lin Xu (Author), Ji-Chan Shi (Author), Wei Shu (Author), Li-Li Cheng (Author), Fei Teng (Author), Yu-Jia Ning (Author), Shi-Heng Xie (Author), Yu-Xian Sun (Author), Li-Jie Zhang (Author), Yu-Hong Liu (Author)
• Format: Book
• Published: BMC, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background World Health Organization recommends countries introducing new drug and short treatment regimen for drug resistant tuberculosis (DR-TB) should develop and implement a system for active pharmacovigilance that allows for detection, reporting and management of adverse events. The ai...